chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative:  Admission: 9/23/2021 Discharge 10/11/2021 DISCHARGE DIAGNOSIS: COVID, Atrial Fibrillation 86 yo M with past medical history of essential tremor, restless legs syndrome, CAD, Atrial fibrillation (on apixaban), COPD, HLD, HTN, and Type 2 Diabetes who presented to the Emergency Department for diarrhea, poor po intake, cough, increased SOB, and generalized weakness for the previous 5-7 days and was found to be COVID positive (despite being fully vaccinated with the Pfizer vaccine (April and May) and in Afib with a rapid ventricular rate (RVR). Over the previous few days to a week he was feeling fatigued and dizzy, especially when standing. He felt too weak to walk. He also endorses a productive cough with clear sputum, increased SOB/DOE, decreased appetite, and intermittent diarrhea. He had been experiencing intermittent R sided chest pressure and palpitations as well. He had been around his son who tested positive for COVID one week ago. Patient initially had to be admitted to the ICU for Afib with RVR in the setting of a COVID infection. CXR without signs of active COVID Pneumonia. Initially satting well on room air, though placed on 2L NC intermittently. He was eventually discharged in stable condition. Symptoms:  & HOSPITALIZATION FOR COVID DESPITE FULL VACCINATON X 2 Treatment:  CASIRIVIMAB/IMDEVIMAB (EUA) 1200 MG ONCE
Swelling lymph nodes- had Moderna shot and swelling started Friday, March 12, 2021.  The pain increased throughout the weekend.  It was difficult to move my arm because of the swelling.  I had to hold my arm next to me in order to not have pain.  I went to the doctor on Monday, March 15 because it was getting worse and I was concerned about what was happening.  Below is the information from my chart at the clinic that the doctor wrote.   Doctor Report- Patient is a 46 year old female  who is here for lymph node evaluation.    Patient states she got her COVID vaccine on Tuesday, and states she has had worsening swelling since the vaccine. States that her pain is 7/10 currently, and she has taken motrin with some relief.  States the first gland that was swollen was present in her right clavicular area, and it is very painful.  States after the shot she had some localized pain in her arm.  She has noticed subsequent swelling of other areas in her neck and shoulder that has emerged over the week since her COVID vaccine.  States she has tried heat pad and icing it without much relief of her pain.  States the pain can relieve with certain positions, and the pain is worsened with movement of her right arm. Denies any symptoms in her left side. Denies any other acute complaints.  States she has taken the motrin once every 4 hours yesterday.  States she didn't really need motrin until Saturday when it was worsening, and Sunday it was worse.   After going to the doctor I continued to monitor the swelling  and took ibuprofen for the week and by day 11 after the shot there was no more swelling.
He didn't sleep good; Tinnitus was reported as worsened / sound was buzzing more; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 63 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Mar2021 09:00 (Lot number: EN6206) at the age of 63 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Tinnitus" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Flu shot. The following information was reported: TINNITUS (non-serious) with onset 15Mar2021, outcome "not recovered", described as "Tinnitus was reported as worsened / sound was buzzing more"; POOR QUALITY SLEEP (non-serious) with onset 28Mar2021, outcome "unknown", described as "He didn't sleep good". The event "tinnitus was reported as worsened / sound was buzzing more" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient stated that he had it about four days in a row when he was listening to music, it sounded like the music was broke and crackling. The events did not result to ER visit. The patient had not received any other vaccines within 4 weeks prior vaccination.   No follow-up attempts are possible. No further information is expected.
A report has been received from a Physician concerning a 6 year old, Female subject, who had been receiving Nasal FLUMIST. FLUMIST started on an unknown date. The patient experienced FEVER and BODY ACHES which started on 28-Nov-2012. The outcome of the event of FEVER and BODY ACHES is unknown. The report was considered to be non-serious.
Extreme inflamation of all joints  Uvitis (Inflamatory Immune Response) inflamtion in eye causing light sensitity, pain, and loss of vision
After first dose: arm pain a few hours after and chills 24 hours later that lasted 24hrs.  Some joint pains persisted.  After second dose: arm pain a few hours after. Twelve hours later I had chills, low grade fever 100.5, body aches, arthralgias, fatigue. These symptoms lasted for 24 hours continuously. 48 hrs later I still had fatigue and early morning chills. The body aches have continued to present time.
Extreme body aches and fatigue . I am nursing a one year old baby. I want to submit this report because I believe that my small size has a 110 pound female as well as the fact that I?m nursing made my body over react to the vaccine. I hope that you provide a lower or lighter version for smaller females to be given this safely. I was so exhausted that my family had to take care of me and my family. The side effects experience from the vaccine were worse than when I had mild Covid 6 months ago, worse than labor, worse than recovering from surgery or any flu I have ever had. I would provide special caution for smaller lighter weight individuals who will take this vaccine and for nursing mothers
Experienced fever, chills, severe headache, body aches, shooting pain in legs for several days. On 3/17/21, experiences severe vertigo with room spinning, dizziness. For the next several weeks, experienced lightheadedness and vertigo, as well as feeling unclear and disconnected.
Hospitalized (10.15-10.22);  COVID-19 positive (10.15);  fully vaccinated  Discharge Provider: MD Primary Care Provider: PA-C Admission Date: 10/15/2021 Discharge Date: Oct 22, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia Pneumonia due to COVID-19 virus HOSPITAL COURSE: Is a 72-year-old COVID-vaccinated female who presented with fever cough and shortness of breath 2 physician, with findings in the office of a pulse oximetry of 86% on room air.  In the emergency room her COVID PCR test was positive and her chest x-ray showed bilateral interstitial pulmonary infiltrates consistent with COVID pneumonia.  On supplemental oxygen her pulse oximetry was 93%.  Patient was treated with 5 days of remdesivir, as well as Decadron until the day of discharge.  She required 3-5 L of oxygen through most of her hospital stay.  Two days prior to her discharge it was noted that she had gained 3 kg of fluid weight, and she was started on IV Lasix diuresis.  With that she had a diuresis of about 6 L of fluid and by the day of discharge she had successfully weaned to room air.  Through her hospital stay she required significant basal bolus insulin dosing for hyperglycemia due to the corticosteroids, but on the day of discharge her blood sugar was down into the 80s and she was not discharged on corticosteroids and therefore is expected to be able to manage her diabetes with her home regimen of oral hypoglycemics. Her only new discharge medication was Lasix 20 mg daily as needed for edema or shortness of breath.  She was requested to follow-up with Dr. in 1 week.  The patient had timed out from isolation in the hospital and was not required to quarantine at discharge.
IN THE WAITING AREA SHORTLY AFTER VACCINATION, PATIENT'S FACE WAS FLUSHING (WARM, RED). SHE ALSO HAD BLURRED VISION. ACCORDING TO HER,  EVERYTHING LOOKED WHITE. HELPED CHECK HER BLOOD PRESSURE, IT WAS NORMAL. WE PUT ICE ON HER NECK, GAVE HER ORANGE JUICE, LIFTED HER LEGS ON A CHAIR . MEDIC CAME IN ABOUT 15 MINUTES AND CHECKED ON HER. SHE GOT BETTER, DIDN'T NEED TO BE TRANSPORTED TO NEARBY ER/HOSPITAL
Sore all over, chills, dehydrated, nausea, headache, can't sleep began at 1:30am Tuesday morning...Wednesday symptoms eased but still sore, chills, headache, some sleep during the night...Thursday symptoms the same as Wednesday no sleep.
patient received their first dose of GARDASIL 9 in November 2018. The second dose of GARDASIL 9 was administered 23-APR-2019.; No adverse effect reported.; This spontaneous report as received from a pharmacy intern refers to a 19 year old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions, allergies or concomitant medications.  In November 2018, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (frequency, route of administration, lot number and expiration date were not reported).   On 23-APR-2019, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) intramuscular in the left arm for prophylaxis (lot # R024264 and expiration date on 29-OCT-2019)(Inappropriate schedule of vaccine administered).No adverse effect reported. The outcome for the event inappropriate schedule of vaccine administered was unknown at the time of this report.
Afluria Quadrivalent MDV 0.25ml was given to a child between the age of 6 month - 35 months.  On the vial, box the vaccines came in and the instruction sheet. It states okay to give this vaccine to these age groups.    6 month - 35 months 0.25ml   36 months and older 0.50ml The state does not approve this vaccine for the age group of 6 months-35 months. -Due to the amount of mercury and its not preservative free. -The vaccine is prepared from virus grown in embryonated chicken egg and inactivated with beta propiolactone. Each 0.25ml dose contains 12.25 mcg mercury/dose Parent states he had no reactions to the vaccine. Parent declined having patents name added to the form. Parent will call the clinic back PRN.
Symptoms started 3-4 days after vaccine.  Began by having rapid, violent coughs.  It then progressed into a shortness of breath.  I would walk very short distances (50 steps) and then would have to sit for two hours to try to catch my breath.  If felt during that time like a pneumonia.  Very shallow breathing and difficulty speaking.
about 36 hours after injection, after waking up, I had vertigo/dizzy spells when changing positions. These lasted over 24 hours depending on activity (which was not much as the early bouts were nauseating). In subsequent days, the dizziness has subsided to much more tolerable levels but still present after waking up or changing from laying down to standing up.
Extreme pain from pinched nerve on left side of neck that has been dormant since physical and medicine therapy.
Pt did not convert p/2 series of Engerix-B vax; recvd last vax 24APR91 & titer 05JUN91 neg;
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from Regulatory Authority. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021259135 (RA). An 84-year-old female patient received bnt162b2 (BNT162B2), administration date 25Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Parkinson's disease" (unspecified if ongoing), notes: Verbatim: Parkinson's disease. The patient's concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 2021, outcome "unknown", described as "Flu like symptoms"; VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "soreness at the injection site". Additional information: The patient stated that she had a mild reaction at first with soreness at the injection site and flu like feeling like she'd rather go lay on the couch for 2 days than do anything else, type symptoms. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No adverse event; An expired Moderna Bivalent Vaccine was administered to patient as the second booster dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (An expired Moderna Bivalent Vaccine was administered to patient as the second booster dose) and NO ADVERSE EVENT (No adverse event) in a 69-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7642B) for COVID-19 prophylaxis.     The patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 02-Jun-2023, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 02-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (An expired Moderna Bivalent Vaccine was administered to patient as the second booster dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (An expired Moderna Bivalent Vaccine was administered to patient as the second booster dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (An expired Moderna Bivalent Vaccine was administered to patient as the second booster dose).    No concomitant medications were provided. No treatment medication was provided.
patient was administered a 2nd dose of the Moderna vaccine at 0.25mL on accident; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (patient was administered a 2nd dose of the Moderna vaccine at 0.25mL on accident) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 26-Oct-2021, the patient experienced ACCIDENTAL UNDERDOSE (patient was administered a 2nd dose of the Moderna vaccine at 0.25mL on accident). On 26-Oct-2021, ACCIDENTAL UNDERDOSE (patient was administered a 2nd dose of the Moderna vaccine at 0.25mL on accident) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.  Patient was administered a 2nd dose of the Moderna vaccine at 0.25mL on accident instead of 0.5mL.
pain in joints, chills, lasting 8 hrs, i took advil exhaustion lasted thru the day and part of the next.
vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication were reported. No treatment medication were reported. Patient did not experience any other adverse reactions.   This case was linked to MOD-2021-395985 (Patient Link).
Injection given in left deltoid and had rash around injection site and warm to touch. Site cleaned with alcohol swab 2 1/2 X 2 width with scattered rash on upper shoulder to collar bone. Temperature 96.9F before injection and 98F, post vax. Complained of headache and dizziness.
per the pt: She reports ongoing flulike symptoms with total body aching, pain described as "severe" in the right hamstring, and stiffness.
Site reaction- R deltoid localized skin erythema, warmth, and tenderness 1 week after vaccination
6 or 7 hrs after the shot, I felt feverish and flushed and these symptoms lasted 3 days. Took temp: no fever.
waking up at 3 am/she was having trouble sleeping and was uncomfortable.; waking up at 3 am/she was having trouble sleeping and was uncomfortable.; headache; feeling chills; muscle soreness; a lot of fatigue; cough; her temperature was at 98.7 when it is usually at 97.2 in the morning; arm swelling, soreness and a warm feeling; arm swelling, soreness and a warm feeling; arm swelling, soreness and a warm feeling; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), via an unspecified route of administration on 14Jan2021 11:00 at single dose for COVID-19 immunization. Medical history included covid-19 from Dec2020 to an unknown date, fatigue from Dec2020 to Jan2021 and cough from Dec2020 to an unknown date, it was reported that she further described the fatigue as the one experienced from getting COVID, 26 days prior to her injection; she mentioned that it was at day 20 post infection that she regained energy from this profound fatigue. She also mentioned that the cough she had during her infection with COVID was back. She then summarized her experience as COVID symptoms but not as severe as when she had it. The patient's concomitant medications were not reported. The patient explained waking up at 3 am, 15 hours post-injection (on 15Jan2021), not knowing how she felt but knew that she was having trouble sleeping and was uncomfortable. She added taking a sleeping pill to help her fall back asleep and woke up at 5:30am. That same day, she said that she experienced: a headache, feeling chills, muscle soreness, a lot of fatigue, and a cough. She specified that her temperature was at 98.7 when it is usually at 97.2 in the morning, as she attributed the rise of temperature to her chills. She said that her fatigue was to the point where it was an effort for her to go up and walk. She then explained that she started to feel better the evening of that first day post injection; and that by the following day, Saturday (on 16Jan2021), the headache was gone and she felt less fatigued. She added also having arm swelling, soreness and a warm feeling in Jan2021. She stated that now 5 days later, her arm was barely tender and was therefore resolving fine. The outcome of the event "having trouble sleeping and was uncomfortable, cough" was not recovered; of the event "headache" was recovered on 16Jan2021; of the events "feeling chills, muscle soreness, a lot of fatigue, arm swelling, soreness and a warm feeling" was recovering; of the rest events was unknown.  Information on the lot/batch number has been requested.
Fell yesterday; Sinus pain; Watery eyes; Been in a fog since the shot; Fever alternating with chills; Muscle and joint aches/Ached all over; Pounding headache; Fever alternating with chills; Muscle and joint aches; My speech has been affected; Balance is off; Sinus drainage; Sore throat; Feels weak; This spontaneous case was reported by a consumer and describes the occurrence of SPEECH DISORDER (My speech has been affected), BALANCE DISORDER (Balance is off), RHINORRHOEA (Sinus drainage), OROPHARYNGEAL PAIN (Sore throat) and ASTHENIA (Feels weak) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 061F21A, 015M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Nov-2021, the patient experienced SPEECH DISORDER (My speech has been affected), BALANCE DISORDER (Balance is off), RHINORRHOEA (Sinus drainage), OROPHARYNGEAL PAIN (Sore throat), ASTHENIA (Feels weak), SINUS PAIN (Sinus pain), LACRIMATION INCREASED (Watery eyes), FEELING ABNORMAL (Been in a fog since the shot), PYREXIA (Fever alternating with chills), MYALGIA (Muscle and joint aches/Ached all over), HEADACHE (Pounding headache), CHILLS (Fever alternating with chills) and ARTHRALGIA (Muscle and joint aches). On 11-Nov-2021, the patient experienced FALL (Fell yesterday). At the time of the report, SPEECH DISORDER (My speech has been affected), BALANCE DISORDER (Balance is off), RHINORRHOEA (Sinus drainage), OROPHARYNGEAL PAIN (Sore throat), ASTHENIA (Feels weak), FALL (Fell yesterday), SINUS PAIN (Sinus pain), LACRIMATION INCREASED (Watery eyes), FEELING ABNORMAL (Been in a fog since the shot), PYREXIA (Fever alternating with chills), MYALGIA (Muscle and joint aches/Ached all over), HEADACHE (Pounding headache), CHILLS (Fever alternating with chills) and ARTHRALGIA (Muscle and joint aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. The patient took Tylenol, but at 2 AM needed to take two more Tylenol.
Feeling sick; Having bad Headache; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ER8733) on 27Mar2021 (at the age of 51-years-old) at single dose for COVID-19 immunization. Medical history included diabetes mellitus. Concomitant medications included ongoing liraglutide (VICTOZA injection) taken at 1.8 ml once a day, injected it came in needle for diabetes mellitus, ongoing metformin 500 mg taken at 500 mg twice a day for diabetes mellitus. The patient experienced feeling sick and having bad headache on 28Mar2021. She stated that she had been feeling sick every day since the day after she went, on 28Mar2021; Saturday night she stopped feeling sick, Sunday she had been sick and then this was been going on from last week until the reporting day; she still felt sick and it was more than 7 days, it was 8-9 days and she still felt sick. She just wanted to know what she could do (treatment) if she continued to feel sick. The patient had not recovered from feeling sick, the outcome of the other event was unknown.   No follow-up attempts are needed. No further information is expected.